Presentation is loading. Please wait.

Presentation is loading. Please wait.

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Published byDaniele Marinelli Modified over 5 years ago

Similar presentations

Presentation on theme: "Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?"— Presentation transcript:

1 Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?
Neel P. Chudgar, MD, Murray F. Brennan, MD, Kay See Tan, PhD, Rodrigo R. Munhoz, MD, Sandra P. D’Angelo, MD, Manjit S. Bains, MD, James Huang, MD, Bernard J. Park, MD, Prasad S. Adusumilli, MD, William D. Tap, MD, David R. Jones, MD  The Annals of Thoracic Surgery  Volume 104, Issue 6, Pages (December 2017) DOI: /j.athoracsur Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Consort diagram for inclusion into analysis. (PM = pulmonary metastasectomy.) The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Overall survival with recurrent metastatic pulmonary soft tissue sarcoma based on treatment after weight-based propensity matching. The p value is calculated from Cox proportional hazards model incorporating matching weights, and repeat PM is considered a time-dependent variable. Considering repeat pulmonary metastasectomy (PM) as a time-dependent variable, the number at risk reflects the number of patients who have undergone repeat PM by the indicated time point. The number may increase as patients are selected for repeat PM during their follow-up. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Overall survival of patients undergoing repeat pulmonary metastasectomy from second resection. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

5 Supplemental Figure 1 The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

6 Supplemental Figure 2 The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?"

Similar presentations

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,

Pulmonary Resection of Metastatic Sarcoma: Prognostic Factors Associated With Improved Outcomes Samuel Kim, MD, Harald C. Ott, MD, Cameron D. Wright, MD,
Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S

Robert M. Kaplan, PhD, Qiankun Sun, PhD, Keith S
Benny Weksler, MD, Jennifer L. Sullivan, MD 

Benny Weksler, MD, Jennifer L. Sullivan, MD 
Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,

Noninvasive Screening for Pulmonary Hypertension by Exercise Testing in Congenital Heart Disease  Jan Müller, PhD, Pinar Bambul Heck, MD, Peter Ewert,
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna.

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma  Arianna.
Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C

Mark W. Onaitis, MD, Rebecca P. Petersen, MD, John C
A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.
Trevor Williams, MD, MPH, Brian C

Trevor Williams, MD, MPH, Brian C
Usman Ahmad, MD, Haoxian Yang, MD, Camelia Sima, MD, MS, Daniel H

Usman Ahmad, MD, Haoxian Yang, MD, Camelia Sima, MD, MS, Daniel H
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison  David M.

Minimally Invasive Versus Sternotomy Approach for Mitral Valve Surgery in Patients Greater Than 70 Years Old: A Propensity-Matched Comparison  David M.
Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma  R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,

Second Primary Lung Cancers: Smokers Versus Nonsmokers After Resection of Stage I Lung Adenocarcinoma  R. Taylor Ripley, MD, Robert R. McMillan, MD, MPH,
Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D
Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E

Linetta B. Koppert, MD, PhD, Albertus N. van Geel, MD, PhD, Titia E
Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C
Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer  Justin A. Drake, MD, David C. Portnoy, MD, Kurt.
Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H
Anthony Lemaire, MD, William R

Anthony Lemaire, MD, William R

Similar presentations

Ads by Google